// App-Quantinova.ai

1397 : CD58-Negtive Leukemia Initiating Cells Are Independently Associated with High Risk of Relapse in B-Precursor Acute Lymphoblastic Leukemia: A Comprehensive Clinical and Biological Profiling Study

Researchers

Presenter

  • Yanrong Liu

Principal Investigators

  • Honghu Zhu

  • Qian Jiang

  • Hao Jiang

  • Lan-Ping Xu

  • Dai-Hong Liu

  • Guo-Rui Ruan

  • Bin Jiang

  • Kaiyan Liu

  • Xiao-Jun Huang

Medical Centers

  • Peking University Peoples Hospital, Peking University Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China

  • Peking University Peoples Hospital, Peking University Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China

Locations

  • China

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Diffuse large B-cell lymphoma

  • Acute lymphoblastic leukemia

  • B cell lymphomas

  • Lymphomas

  • B-cell acute lymphoblastic leukemia

  • Lung disease, immunodeficiency, and chromosome breakage syndrome

Biomarkers

  • Cluster of Differentiation 19

  • Cluster of Differentiation 2

  • Cluster of Differentiation 34

  • Cluster of Differentiation 38

  • White Blood Cell

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim